Internal Medicine, Rheumatology · Poway, CA
NPI
1750534715
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
15725 Pomerado Rd Ste 117
Poway, CA, 92064
Phone (858) 312-1717
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
6,567 services
Medicare patients, 2024
182
Average age 73
Drug cost, 2024
$2.3M
1,744 prescriptions
Company payments, 2025
$3,792
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Smitha Reddy was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,635 times for 24 patients. In total Smitha Reddy billed 6,567 services in 47 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,635 | 24 | $0.10 | $170 |
| 76881 Ultrasound - Nonspecific | Office | 824 | 129 | $43.52 | $36K |
| 99214 Office E&M - Established | Office | 758 | 167 | $101.23 | $77K |
| 86235 Immunoassay | Office | 525 | 66 | $17.57 | $9,225 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 518 | 56 | $0.49 | $255 |
| 83520 Immunoassay | Office | 296 | 65 | $16.93 | $5,010 |
| 86147 Immunoassay | Office | 225 | 66 | $24.94 | $5,612 |
| 86146 Immunoassay | Office | 222 | 66 | $24.94 | $5,537 |
| 36415 Venipuncture Blood Collection | Office | 176 | 98 | $8.65 | $1,522 |
| 83516 Immunoassay | Office | 149 | 66 | $11.30 | $1,684 |
| 20611 Joint Injection | Office | 123 | 49 | $92.67 | $11K |
| 96372 Injection Administration | Office | 91 | 42 | $12.20 | $1,110 |
| 73130 X-ray - Upper Extremity | Office | 86 | 39 | $32.01 | $2,753 |
| 86226 Immunoassay | Office | 75 | 66 | $11.87 | $890 |
| 86225 Immunoassay | Office | 75 | 66 | $13.47 | $1,010 |
By year: 2022 $198K for 4,543 services; 2023 $199K for 5,911 services; 2024 $189K for 6,567 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 525 | 66 | $17.57 | $9,225 |
| 83520 Immunoassay | 296 | 65 | $16.93 | $5,010 |
| 86147 Immunoassay | 225 | 66 | $24.94 | $5,612 |
| 86146 Immunoassay | 222 | 66 | $24.94 | $5,537 |
| 36415 Venipuncture Blood Collection | 176 | 98 | $8.65 | $1,522 |
| 83516 Immunoassay | 149 | 66 | $11.30 | $1,684 |
| 86225 Immunoassay | 75 | 66 | $13.47 | $1,010 |
| 86226 Immunoassay | 75 | 66 | $11.87 | $890 |
| 86376 Immunoassay | 74 | 66 | $14.26 | $1,055 |
| 86431 Immunoassay | 74 | 66 | $5.56 | $411 |
Medicare prescription drug claims, 2024
In 2024, the drug Smitha Reddy prescribed most often to Medicare patients was Prednisone, with 184 prescriptions and refills. In total Smitha Reddy wrote 1,744 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 184 | 206 | 58 | $815 |
| Methotrexate Methotrexate Sodium | 167 | 246 | 44 | $2,838 |
| Leflunomide Generic | 161 | 235 | 43 | $5,741 |
| Hydroxychloroquine Sulfate Generic | 101 | 192 | 32 | $4,769 |
| Gabapentin Generic | 89 | 146 | 19 | $1,546 |
| Sulfasalazine Generic | 67 | 107 | 24 | $1,434 |
| Folic Acid Generic | 59 | 103 | 18 | $185 |
| Alendronate Sodium Generic | 57 | 92 | 19 | $212 |
| Duloxetine Hcl Generic | 54 | 111 | 13 | $1,700 |
| Simponi Golimumab | 52 | 61 | 15 | $362K |
| Pregabalin Generic | 42 | 50 | 11 | $1,004 |
| Humira(Cf) Pen Adalimumab | 39 | 39 | Under 11 | $331K |
| Celecoxib Generic | 37 | 39 | 18 | $2,588 |
| Forteo Teriparatide | 33 | 35 | Under 11 | $144K |
| Diclofenac Sodium Generic | 33 | 34 | 15 | $425 |
Brand drugs: 411 claims; generic drugs: 1,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Smitha Reddy $3,792 ($3,792 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $773.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 43 | $773 |
| Amgen Inc. AMGN | 24 | $540 |
| UCB, Inc. UCB.BR | 24 | $449 |
| Novartis Pharmaceuticals Corporation NVS | 31 | $395 |
| Janssen Biotech, Inc. JNJ | 27 | $271 |
| Mallinckrodt Hospital Products Inc. | 11 | $249 |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $224 |
| Lilly USA, LLC LLY | 10 | $194 |
| GlaxoSmithKline, LLC. GSK | 9 | $171 |
| Pfizer Inc. PFE | 5 | $119 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.